"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
STATICIN (erythromycin topical solution 1.5%) is contraindicated in those individuals who have shown hypersensitivity to any of its components.
Last reviewed on RxList: 2/3/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Staticin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.